Viewing StudyNCT00282282



Ignite Creation Date: 2024-05-05 @ 4:38 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00282282
Status: COMPLETED
Last Update Posted: 2014-05-12
First Post: 2006-01-24

Brief Title: Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
GVHD
Graft Versus Host Disease
Keywords:
Name View
sirolimus View
non-myeloablative peripheral blood stem cell View
PBSCT View
tacrolimus View